Marchex (MCHX) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Aug, 2026Executive summary
Completed acquisition of Archenia on July 1, 2026, enhancing AI-powered conversational analytics and expanding the customer base across major verticals including automotive, insurance, and healthcare.
Revenue for Q2 2026 was $11.0 million, down 6% year-over-year from $11.7 million, with a net loss of $0.4 million versus net income of $0.1 million in Q2 2025.
Combined platform aims to deliver measurable business value by connecting insights, automated actions, and outcomes, with strong initial adoption and upsell momentum among top customers.
The company settled litigation related to the Telmetrics acquisition for $2.0 million, resolving all related claims.
Top 100 customers represent about 90% of revenue, with significant early adoption of new AI-powered offerings and pilots.
Financial highlights
Q2 2026 revenue was $11.0 million, down from $11.7 million in Q2 2025, driven by new sales, upsells, and customer migrations.
Net loss for Q2 2026 was $0.4 million, or $(0.01) per diluted share; Adjusted EBITDA improved to $0.7 million, or $1.7 million excluding $1.0 million in reorganization/acquisition costs.
Operating expenses decreased due to lower sales, marketing, and product development costs, partially offset by nonrecurring acquisition-related charges.
Cash and cash equivalents at June 30, 2026, were $8.2 million, down from $9.9 million at year-end 2025, mainly due to transaction and realignment expenses.
Pro forma combined Q2 2026 revenue was $15.5 million with Adjusted EBITDA of $1.0 million (or $2.0 million excluding acquisition costs).
Outlook and guidance
Q3 2026 revenue expected at $16.0–$16.5 million, with Adjusted EBITDA of $2.3–$2.5 million, reflecting a full quarter of Archenia results.
Fourth quarter and 2027 outlook to be provided with Q3 results in early November 2026.
Management expects sufficient resources to fund operations for at least twelve months, but macroeconomic factors could influence plans and resources.
Additional equity or debt financing may be needed to support acquisition strategy and long-term obligations.
Targeting Rule of 30–40 trajectory (annual revenue growth plus adjusted EBITDA margin).
Latest events from Marchex
- Shareholders will vote on acquiring Archenia, with independent oversight and dual-majority approval required.MCHX
Proxy filing - Shareholders to vote on acquiring Archenia for $10M in notes and up to 4M shares, with Board support.MCHX
Proxy filing - Board-approved Archenia acquisition aims to accelerate growth and margin expansion in 2026.MCHX
Proxy filing - AI-driven products, improved margins, and the Archenia deal set the stage for future growth.MCHX
Q1 2026 - Acquisition of Archenia, Inc. for $10M in notes and up to 4M shares awaits stockholder approval.MCHX
Proxy filing - 2025 revenue fell, but AI solutions and Archenia deal position for strong 2026 growth.MCHX
Q4 2025 - Net loss narrowed and adjusted EBITDA improved as revenue is set to grow in Q3.MCHX
Q2 2024 - Q1 2025 revenue was $11.4M, net loss $2.0M, and gross margin rose to 63% with SaaS expansion.MCHX
Q1 2025 - 2025 is set for sequential growth and margin gains, fueled by new AI products and a Microsoft partnership.MCHX
Q4 2024